Leptin Inhibits Bone Formation through a Hypothalamic Relay A Central Control of Bone Mass

Gonadal failure induces bone loss while obesity prevents it. This raises the possibility that bone mass, body weight, and gonadal function are regulated by common pathways. To test this hypothesis, we studied leptin-deficient and leptin receptor-deficient mice that are obese and hypogonadic. Both mutant mice have an increased bone formation leading to high bone mass despite hypogonadism and hypercortisolism. This phenotype is dominant, independent of the presence of fat, and specific for the absence of leptin signaling. There is no leptin signaling in osteoblasts but intracerebroventricular infusion of leptin causes bone loss in leptin-deficient and wild-type mice. This study identifies leptin as a potent inhibitor of bone formation acting through the central nervous system and therefore describes the central nature of bone mass control and its disorders.

[1]  J. Friedman,et al.  Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[2]  G Shimamoto,et al.  Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone Density , 1997, Cell.

[3]  J. Flier,et al.  Leptin accelerates the onset of puberty in normal female mice. , 1997, The Journal of clinical investigation.

[4]  C. Saper,et al.  From Lesions to Leptin Hypothalamic Control of Food Intake and Body Weight , 1999, Neuron.

[5]  E. Brown,et al.  Ubiquitin-related proteins regulate interaction of vimentin intermediate filaments with the plasma membrane. , 1999, Molecular cell.

[6]  G. Karsenty,et al.  A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. , 1999, Genes & development.

[7]  G. Bray,et al.  The effects of subdiaphragmatic vagotomy in rats with ventromedial hypothalamic obesity. , 1977, Endocrinology.

[8]  Activation of the JAK-STAT signal transduction pathway by oncostatin-M cultured human and mouse osteoblastic cells. , 1996, Endocrinology.

[9]  W. Chung,et al.  Fine structure of the murine leptin receptor gene: splice site suppression is required to form two alternatively spliced transcripts. , 1997, Genomics.

[10]  D. Eyre,et al.  Collagen cross-linking in human bone and articular cartilage. Age-related changes in the content of mature hydroxypyridinium residues. , 1988, The Biochemical journal.

[11]  C. Mantzoros,et al.  Role of leptin in the neuroendocrine response to fasting , 1996, Nature.

[12]  J. Darnell,et al.  Leptin activation of Stat3 in the hypothalamus of wild–type and ob/ob mice but not db/db mice , 1996, Nature Genetics.

[13]  L. Melton,et al.  Chapter 21 – Magnitude and Impact of Osteoporosis and Fractures , 2001 .

[14]  I. Reid Preventing glucocorticoid-induced osteoporosis. , 1997, The New England journal of medicine.

[15]  K. Yasuda,et al.  New method for genotyping the mouse Lep(ob) mutation, using a polymerase chain reaction assay. , 1998, Laboratory animal science.

[16]  D. Coleman,et al.  Laboratory animals exhibiting obesity and diabetes syndromes. , 1977, Metabolism: clinical and experimental.

[17]  M. Jensen,et al.  Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. , 1999, Endocrinology.

[18]  A. Inui Feeding and body-weight regulation by hypothalamic neuropeptides—mediation of the actions of leptin , 1999, Trends in Neurosciences.

[19]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1994, Nature.

[20]  J. Friedman,et al.  Abnormal splicing of the leptin receptor in diabetic mice , 1996, Nature.

[21]  R. Palmiter,et al.  Attenuation of the Obesity Syndrome of ob/ob Mice by the Loss of Neuropeptide Y , 1996, Science.

[22]  J. Flier,et al.  Printed in U.S.A. Copyright © 1999 by The Endocrine Society Regulation of Neuronal and Glial Proteins by Leptin: Implications for Brain Development* , 2022 .

[23]  J. Flier,et al.  Identification of SOCS-3 as a potential mediator of central leptin resistance. , 1998, Molecular cell.

[24]  J. Kaufman,et al.  Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary deficiencies of childhood onset. , 1992, The Journal of clinical endocrinology and metabolism.

[25]  R. Baron,et al.  Rescue of the Skeletal Phenotype of Vitamin D Receptor-Ablated Mice in the Setting of Normal Mineral Ion Homeostasis: Formal Histomorphometric and Biomechanical Analyses1. , 1999, Endocrinology.

[26]  T. Martin,et al.  Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. , 1999, Endocrine reviews.

[27]  B. Spiegelman,et al.  Adipogenesis and Obesity: Rounding Out the Big Picture , 1996, Cell.

[28]  Everett M. Rogers,et al.  Consensus Development Conference , 1984 .

[29]  R. Considine,et al.  Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance , 1996, The Lancet.

[30]  T. Martin,et al.  A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro. , 1998, Endocrinology.

[31]  F. Chehab,et al.  Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin , 1996, Nature Genetics.

[32]  C. Christiansen,et al.  Low Body Mass Index Is an Important Risk Factor for Low Bone Mass and Increased Bone Loss in Early Postmenopausal Women , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[33]  R. Considine,et al.  Serum immunoreactive-leptin concentrations in normal-weight and obese humans. , 1996, The New England journal of medicine.

[34]  E. Ravussin,et al.  Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects , 1995, Nature Medicine.

[35]  Rene Devos,et al.  Identification and expression cloning of a leptin receptor, OB-R , 1995, Cell.

[36]  J J Anderson,et al.  Effects of weight and body mass index on bone mineral density in men and women: The framingham study , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[37]  M. Olive,et al.  Life without white fat: a transgenic mouse. , 1998, Genes & development.

[38]  J. Flier,et al.  Insulin resistance--mechanisms, syndromes, and implications. , 1991, The New England journal of medicine.

[39]  L. Tartaglia,et al.  The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[40]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1995, Nature.

[41]  L. Tartaglia,et al.  Evidence That the Diabetes Gene Encodes the Leptin Receptor: Identification of a Mutation in the Leptin Receptor Gene in db/db Mice , 1996, Cell.

[42]  C. Saper,et al.  Leptin activates neurons in ventrobasal hypothalamus and brainstem. , 1997, Endocrinology.

[43]  B. L. Riggs,et al.  A Unitary Model for Involutional Osteoporosis: Estrogen Deficiency Causes Both Type I and Type II Osteoporosis in Postmenopausal Women and Contributes to Bone Loss in Aging Men , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[44]  R. Skoda,et al.  Defective STAT signaling by the leptin receptor in diabetic mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[45]  M. Drezner,et al.  Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee , 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[46]  D. Lacey,et al.  Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and Activation , 1998, Cell.

[47]  J. Halaas,et al.  Leptin and the regulation of body weight in mammals , 1998, Nature.

[48]  Y. J. Kim,et al.  Evidence for B_s^0 -> Lambda_c^+ Lambda-bar pi^- , 2013, 1304.6931.

[49]  J. Pouilles,et al.  Vertebral postmenopausal bone loss is reduced in overweight women: a longitudinal study in 155 early postmenopausal women. , 1993, The Journal of clinical endocrinology and metabolism.